Search

everythinglearnresearchcommunity

for

Search:↓

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Kampo medicine can help treat general fatigue from long COVID.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Human hair follicle stem cells help repair tendon injuries.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Redefining drug dosages is crucial when repurposing them for new uses.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.